Margareta Steinwall (Former)
1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine
(
- Contribution to journal › Article
- 2006
-
Mark
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
(
- Contribution to journal › Article
-
Mark
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18
(
- Contribution to journal › Article
- 2005
-
Mark
The effect of relcovaptan (SR 49059), an orally active vasopressin V1a receptor antagonist, on uterine contractions in preterm labor.
(
- Contribution to journal › Article
-
Mark
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
(
- Contribution to journal › Article
- 2004
-
Mark
Inhibitory effects of SR 49059 on oxytocin-and vasopressin-induced uterine contractions in non-pregnant women.
(
- Contribution to journal › Article
-
Mark
ONO-8815Ly, an EP2 agonist that markedly inhibits uterine contractions in women.
(
- Contribution to journal › Article
-
Mark
Oxytocin mRNA content in the endometrium of non-pregnant women.
(
- Contribution to journal › Article
- 2003
-
Mark
FE 200 440: a selective oxytocin antagonist on the term-pregnant human uterus.
(
- Contribution to journal › Article
-
Mark
Involvement of vasopressin and oxytocin in the regulation of human uterine activity
2003)(
- Thesis › Doctoral thesis (compilation)